The Biomedical Informatics Entrepreneurs Salon (BIES), which the department cohosts with Harvard University's Office of Technology Development, meets regularly to promote entrepreneurship at the convergence of biology, medicine, and computing. In addition to hearing industry leaders speak, participants will have the chance to look for collaborators, employees, advisors, customers, or investors.

BIES is open to everyone. Tickets are free but limited, and registration is required.

Join our mailing list to receive invitations to future events.


Upcoming
  • 2/15/24 – Morgan Cheatham, Bessemer Venture Partners – REGISTER
  • 3/19/24 – Christina Farr, OMERS Ventures – Registration coming soon
  • April–May events also coming soon

Past
  • 1/17/24 – Molly Gibson, Generate Biomedicines
  • 12/12/23: Anne Heatherington, Takeda
  • 11/14/23: Atul Butte, UCSF
  • 10/24/23: Ann DeWitt, The Engine
  • 9/27/23: William Lotter, DFCI
  • 5/18/23: Howard Jacob, Abbvie
  • 4/20/23: Linda Avey, Precise.ly (Co-founder of 23andMe)
  • 3/21/23: Isaac Kohane, interviewed by David Shaywitz
  • 2/15/23: Daniel Day, Meta
  • 1/26/23: Iris Grossman, Eleven Therapeutics
  • 12/15/22: Nigam Shah, Stanford
  • 11/8/22: Anne Wojcicki, 23andMe
  • 10/6/22: Simon MacGibbon, Myia Health
  • 9/8/22: Lovina McMurchy, Movac Capital
  • 6/1/22: Keith R. Dunleavy, Inovalon
  • 4/27/22: Vivian S. Lee, Verily Life Sciences
  • 3/24/22: Diana Brainard, AlloVir
  • 2/15/22: Tania Simoncelli, Chan Zuckerberg Initiative
  • 1/19/22: Caitlin Donovan, Uber Health
  • 12/8/21: Kathy Giusti, Multiple Myeloma Research Foundation
  • 11/17/21: Najat Khan, Janssen Research & Development, LLC
  • 10/27/21: Michal Preminger, Johnson & Johnson Innovation, East North America
  • 9/23/21: Jeremy Howard, fast.ai
  • 2/3/21: Sara Choi, Wing VC
  • 3/24/21: Levi Garraway, Roche and Genentech
  • 4/21/21: Stephen Kahane, New Mountain Capital
  • 5/19/21: Jini Kim, Nuna
  • 1/21/21: Daphne Zohar, PureTech
  • 11/4/20: Blake Byers, Google Ventures
  • 9/16/20: Arnaub Chatterjee, Medidata/AcornAI
  • 5/19/20: Grant Weller, UnitedHealth Group
  • 1/22/20: Aaron Abend, Prognosis Data Corp
  • 12/10/19: Andy Coravos and Sofia Warner, Elektra Labs
  • 11/6/19: Jay Bradner,  Novartis Institutes for BioMedical Research (NIBR)
  • 10/2/19: Jamie Heywood, Patients Like Me
  • 6/12/19: Scott Barclay, DCVC
  • 5/7/19: Michael E. Zalis, One Brave Idea
  • 4/10/19: Tom Knight, Ginkgo Bioworks
  • 3/7/19: Krishna Yeshwant, Google Ventures
  • 2/7/19: Kurt Rohloff, Duality Technologies; Alexander "Sasha" Gusev, Dana-Farber Cancer Institute
  • 12/18/18: Gail H. Javitt, Epstein Becker Green
  • 11/28/18: Peter Lee, Microsoft Healthcare
  • 9/17/18: Kristin Pothier, EY Parthenon
  • 5/3/18: Sumita Pennathur, University of California Santa Barbara
  • 4/17/18: John S. Brownstein, Boston Children's Hospital
  • 3/5/18: Roman Yelensky, Gritstone Oncology
  • 11/30/17: Lisa Suennen, GE Ventures
  • 10/30/17: David Botstein, Calico
  • 9/15/17: Rich Gliklich, General Catalyst Ventures, OM1, Inc.
  • 5/24/17: Colin Hill, GNS Healthcare
  • 4/26/17: Jonathan Bush, athenahealth
  • 3/29/17: Jennifer Chayes, Microsoft Research
  • 2/22/17: Will Crawford, Fitbit
  • 1/25/17: D. Levin Brown, FleetHealth
  • 11/7/16: David Shaywitz, DNAnexus
  • 9/19/16: David De Graaf, Syntimmune
  • 6/16/16: Chris Colbert, Harvard i-Lab; Dan Gebremedhin, Flare Capital Partners
  • 5/26/16: Roz Picard, Empatica
  • 4/21/16: David Altshuler, Vertex; Luba Greenwood, Roche
  • 3/24/16: Aman Bhandari, Merck; John Boyce, CEO Exosome Diagnostics [Photo Gallery]